Overview
Matthew Ko is chief executive officer and co-founder of DeepScribe, a company helping clinicians rediscover their connection with patients using ambient AI technology to unburden them from hours of charting and administrative work since 2017 per the about page. DeepScribe’s Ambient Operating System is in more than 1,500 healthcare organizations with AI models fine-tuned for complex specialties and provider preferences.
Ko’s personal motivation — serving as care coordinator for his mother during breast cancer treatment — opened his eyes to how disconnected and overwhelming healthcare can feel, a founding story documented on DeepScribe’s about page.
Role and company
As CEO and Cofounder, Ko leads DeepScribe’s vision of healthcare where technology disappears into the background, clinicians are present, patients feel heard, and the joy of care is standard not luxury. DeepScribe is the leader in ambient AI for community oncology per its about page — where care complexity, team coordination, and emotional demand are highest.
DeepScribe reports 2,800+ clinics and health systems served, 8 million+ visits captured, and 99.92% note satisfaction rating on its about page.
Background and career context
DeepScribe’s about page establishes Ko as CEO and cofounder with founding in 2017 and expertise in natural language processing, machine learning, and data analytics cited on the company site. His mother’s breast cancer care coordination experience shaped DeepScribe’s patient-centered founding narrative.
Ko’s oncology specialization strategy addresses a segment where documentation complexity and multidisciplinary coordination exceed primary care ambient AI capabilities.
Company-building or leadership context
Under Ko, DeepScribe emerged as an early ambient AI leader when the category was nascent, then scaled to 1,500+ organizations with onsite teams and ongoing clinical feedback for community oncology per about page. DeepScribe emphasizes dedication to complex care delivery, commitment to specialty workflows beyond documentation, and focus on simplifying complexity for clinicians.
Ko’s CEO tenure spans from pioneer phase through competitive bake-offs against Abridge, Ambience, and other KLAS-ranked ambient vendors.
Public milestones
2017: DeepScribe founded; ambient AI for documentation. About page cites 2,800+ clinics served, 8M+ visits, 99.92% note satisfaction. DeepScribe markets community oncology leadership with expert onsite teams per about page reviewed 2026.
Ko is named CEO and Cofounder on deepscribe.ai/about reviewed July 10, 2026.
Why their work matters
DeepScribe under Ko proves ambient AI winners may emerge from specialty depth — oncology complexity and team coordination — rather than horizontal primary-care scribing alone. 99.92% note satisfaction gives enterprise buyers a quantified quality metric beyond vendor demos.
For healthcare AI readers, Ko’s DeepScribe competes directly with Abridge and Ambience but anchors on community oncology workflows and onsite partnership models.
Sources and references
Primary sourcing: DeepScribe About page, reviewed July 10, 2026.
- DeepScribe — About (deepscribe.ai)
Visit counts and satisfaction metrics from DeepScribe about page only.
DeepScribe about page cites trusted relationships with respected oncology organizations and expert onsite teams with ongoing clinical feedback — a high-touch deployment model Ko uses to defend community oncology market share against horizontal ambient AI vendors selling primarily through virtual implementation. 99.92% note satisfaction and 8 million+ visits captured give Ko quantified quality metrics for enterprise oncology committee evaluations.
DeepScribe markets dedication to complex care delivery, commitment to specialty workflows beyond documentation, and focus on simplifying complexity for clinicians per about page product principles Ko communicates as CEO. Founded 2017 per about timeline, DeepScribe predates many ambient AI competitors in oncology specialization.